Katherine Levy
Apr 14, 2011

Novartis to review US$600m global media business

GLOBAL - Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated US$600 million global media business.

Novatris currently works with incumbent MEC
Novatris currently works with incumbent MEC

WPP's MEC is the incumbent on the global business.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

This article was first published on campaignlive.co.uk.

Source:
Campaign Asia

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

1 hour ago

Why Meta’s pivot on fact-checking is the right move

This course correction is not merely expedient; it’s the right move for Meta, its shareholders, advertisers, and audiences alike, argues Ramakrishnan Raja in his forthright analysis.

1 day ago

Former Dentsu China CEO Deric Wong joins EternityX

EXCLUSIVE: The media agency veteran who left Dentsu China to start a consulting firm will oversee the global expansion at the Hong Kong-headquartered martech company.

1 day ago

Top 10 travel brands in Southeast Asia

Vietnam Airlines soars above the competition, claiming the title of Southeast Asia’s top travel brand in 2024. Explore Campaign’s exclusive insights from its research with Milieu Insight.